Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,060 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.
Kimball AB, Jemec GBE, Sayed CJ, Kirby JS, Prens E, Ingram JR, Garg A, Gottlieb AB, Szepietowski JC, Bechara FG, Giamarellos-Bourboulis EJ, Fujita H, Rolleri R, Joshi P, Dokhe P, Muller E, Peterson L, Madden C, Bari M, Zouboulis CC. Kimball AB, et al. Among authors: gottlieb ab. Lancet. 2024 May 22:S0140-6736(24)00101-6. doi: 10.1016/S0140-6736(24)00101-6. Online ahead of print. Lancet. 2024. PMID: 38795716
Dendritic Cell Immune Modulation via Polyphenol Membrane Coatings.
Janes ME, Park KS, Gottlieb AP, Curreri A, Adebowale K, Kim J, Mitragotri S. Janes ME, et al. Among authors: gottlieb ap. ACS Appl Mater Interfaces. 2024 May 23. doi: 10.1021/acsami.4c01575. Online ahead of print. ACS Appl Mater Interfaces. 2024. PMID: 38779939
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who had inadequate efficacy and/or intolerance to one prior tumor necrosis factor inhibitor: study protocol for SOLSTICE, a phase 3B, multicenter, randomized, double-blind, placebo-controlled study.
Ogdie A, Merola JF, Mease PJ, Ritchlin CT, Scher JU, Lafferty KP, Chan D, Chakravarty SD, Langholff W, Wang Y, Choi O, Krol Y, Gottlieb AB. Ogdie A, et al. Among authors: gottlieb ab. BMC Rheumatol. 2024 May 21;8(1):20. doi: 10.1186/s41927-024-00386-7. BMC Rheumatol. 2024. PMID: 38773563 Free PMC article.
Polymer Micropatches as B-Cell Engagers.
Prakash S, Kumbhojkar N, Gottlieb AP, Park KS, Kapate N, Mitragotri S. Prakash S, et al. Among authors: gottlieb ap. ACS Appl Mater Interfaces. 2024 May 21. doi: 10.1021/acsami.4c04385. Online ahead of print. ACS Appl Mater Interfaces. 2024. PMID: 38770711
1,060 results